Article info
PDFShort report
Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safety
- Correspondence to Professor John R Gosney, Cellular Pathology, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool L7 8XP, UK; J.Gosney{at}liverpoolft.nhs.uk
Citation
Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safety
Publication history
- Received May 22, 2020
- Accepted May 27, 2020
- First published June 1, 2020.
Online issue publication
December 11, 2020
Article Versions
- Previous version (1 June 2020).
- Previous version (1 July 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.